Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Kodiak Sciences (KOD) Stock Price & Analysis

KOD Stock Chart & Stats

MX$1,850.00MX$350.00(23.33%)
At close:
MXN 1,500MXN 1,600MXN 1,700MXN 1,80014 Oct30 Oct
Day’s Range
MXN 1,850.00 - MXN 1,850.00
52-Week Range
MXN 51.00 - MXN 1,850.00
Previous Close
MXN 1,500.00
Volume
0
Average Volume (3M)
7
Market Cap
MXN 117.10B
Enterprise Value
MXN 2.47B
Total Cash (Recent Filing)
MXN 125.90M
Total Debt (Recent Filing)
MXN 95.70M
Price to Earnings (P/E)
―
Beta
4.85
Next Earnings
Nov 12, 2026 (Est.)
EPS Estimate
-19.95
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Phase 3 Efficacy And Durability

Positive Phase 3 results establish clinical efficacy for two retinal programs, while six-month dosing durability could reduce treatment frequency. This supports differentiation in a large ophthalmology market, strengthens the approval case, and improves the potential commercial value of Kodiak’s pipeline over the next several quarters.

Validated Retinal Platform

Repeated positive late-stage results across wet AMD, diabetic retinopathy, and retinal vein occlusion provide broader validation than a single trial outcome. This multi-indication evidence may support development efficiency, enhance confidence in the ABC platform, and create a foundation for a durable retinal franchise.

Lower Debt Burden

Material year-over-year debt reduction lowers balance-sheet leverage and can reduce financing pressure relative to the prior year. Although Kodiak remains financially constrained, a smaller debt burden improves flexibility around future development spending and may limit the extent to which creditors compete with pipeline investment.

Bears Say

No Commercial Revenue

Kodiak has not yet demonstrated recurring product revenue, so its ability to fund operations depends on financing, collaborations, or future regulatory and commercial success. Until a therapy is approved and adopted, the company lacks an established revenue base to absorb development costs or offset operating losses.

Persistent Cash Burn

Sustained negative operating and free cash flow means Kodiak continues consuming capital to advance its programs rather than generating internal funding. This increases dependence on external financing or strategic transactions and could constrain development choices if access to capital becomes less favorable.

Shrinking Equity Base

Sharp equity contraction reduces the balance-sheet cushion available to support ongoing clinical development and commercialization preparation. Combined with deeply negative returns on equity and continuing losses, the smaller capital base leaves less flexibility to absorb setbacks and heightens the importance of future funding.

Kodiak Sciences News

KOD FAQ

What was Kodiak Sciences’s price range in the past 12 months?
Kodiak Sciences lowest stock price was Mex$51.00 and its highest was Mex$1850.00 in the past 12 months.
What is Kodiak Sciences’s market cap?
Kodiak Sciences’s market cap is Mex$117.10B.
When is Kodiak Sciences’s upcoming earnings report date?
Kodiak Sciences’s next earnings report is estimated for Nov 12, 2026 (not yet confirmed), which is in 11 days.
How were Kodiak Sciences’s earnings last quarter?
Kodiak Sciences released its earnings results on Aug 13, 2026. The company reported -Mex$19.725 earnings per share for the quarter, missing the consensus estimate of -Mex$17.959 by -Mex$1.766.
Is Kodiak Sciences overvalued?
According to Wall Street analysts Kodiak Sciences’s price is currently Undervalued.
Does Kodiak Sciences pay dividends?
Kodiak Sciences does not currently pay dividends.
What is Kodiak Sciences’s EPS estimate?
Kodiak Sciences’s EPS estimate is -19.95.
How many shares outstanding does Kodiak Sciences have?
Kodiak Sciences has 62,849,457 shares outstanding.
What happened to Kodiak Sciences’s price movement after its last earnings report?
Kodiak Sciences reported an EPS of -Mex$19.725 in its last earnings report, missing expectations of -Mex$17.959. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Kodiak Sciences?
Currently, no hedge funds are holding shares in MX:KOD
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology